Cargando…

Clinical efficacy of carvedilol treatment for dilated cardiomyopathy: A meta-analysis of randomized controlled trials

BACKGROUND: Clinical trials examining the therapeutic benefit of carvedilol on patients with dilated cardiomyopathy have reported inconsistent results. The aim of this study was to evaluate the clinical efficacy of carvedilol on patients with dilated cardiomyopathy. METHODS: PubMed, Embase, Cochrane...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Tao, Yuan, Guoliang, Ma, Chengbin, Jin, Peng, Zhou, Changgao, Li, Wei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6504318/ https://www.ncbi.nlm.nih.gov/pubmed/31045794 http://dx.doi.org/10.1097/MD.0000000000015403

Ejemplares similares

Efficacy of Carvedilol in Patients with Dilated Cardiomyopathy due to Beta-thalassemia major; a Double-blind Randomized Controlled Trial
por: Ajami, Gholam-Hossein, et al.
Publicado: (2010)

The Role of Carvedilol in the Treatment of Dilated and Anthracyclines-Induced Cardiomyopathy
por: Watanabe, Kenichi, et al.
Publicado: (2011)

Efficacy of L-Carnitine for Dilated Cardiomyopathy: A Meta-Analysis of Randomized Controlled Trials
por: Weng, Yayun, et al.
Publicado: (2021)

Effects of carvedilol therapy on cardiac autonomic control, QT dispersion, and ventricular arrhythmias in children with dilated cardiomyopathy
por: Oflaz, Mehmet Burhan, et al.
Publicado: (2013)

Efficacy and Safety of Qili Qiangxin Capsule on Dilated Cardiomyopathy: A Systematic Review and Meta-Analysis of 35 Randomized Controlled Trials
por: Wei, Jingjing, et al.
Publicado: (2022)

Real-World Use of Carvedilol in Children With Dilated Cardiomyopathy: Long-Term Effect on Survival and Ventricular Function
por: Adorisio, Rachele, et al.
Publicado: (2022)

Heart rate reduction as a marker to optimize carvedilol treatment and enhance myocardial recovery in pediatric dilated cardiomyopathy
por: Adorisio, Rachele, et al.
Publicado: (2022)

Preventive role of carvedilol in adriamycin-induced cardiomyopathy
por: Jhorawat, Rajesh, et al.
Publicado: (2016)

The Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) trial
por: Eichhorn, Eric J, et al.
Publicado: (2001)

Shared Genetic Etiology of Primary Dilated Cardiomyopathy and Ischemic Dilated Cardiomyopathy
por: Sun, Yang, et al.
Publicado: (2021)

Cell therapy for nonischemic dilated cardiomyopathy: A systematic review and meta‐analysis of randomized controlled trials
por: Tripathi, Avnish, et al.
Publicado: (2021)

Enantioselective Resolution of (R,S)-Carvedilol to (S)-(−)-Carvedilol by Biocatalysts
por: Ettireddy, Swetha, et al.
Publicado: (2017)

Carvedilol in the treatment of chronic heart failure: Lessons from The Carvedilol Or Metoprolol European Trial
por: Kveiborg, Britt, et al.
Publicado: (2007)

Efficacy and safety of stem cell therapy in patients with dilated cardiomyopathy: a systematic appraisal and meta-analysis
por: Rong, Shu-Ling, et al.
Publicado: (2019)

Dilated cardiomyopathy
por: Schultheiss, Heinz-Peter, et al.
Publicado: (2019)

Apoptosis in Dilated Cardiomyopathy
por: Hong, Bum Kee, et al.
Publicado: (2000)

Carvedilol for portal hypertension in cirrhosis: systematic review with meta-analysis
por: Li, Tong, et al.
Publicado: (2016)

Immunoadsorption treatment for dilated cardiomyopathy: A PRISMA-compliant systematic review and meta-analysis
por: Bian, Ru-tao, et al.
Publicado: (2021)

Effects of stem cell therapy on dilated cardiomyopathy
por: Jiao, Rong, et al.
Publicado: (2014)

Comparative Efficacy of Different Drugs for the Treatment of Dilated Cardiomyopathy: A Systematic Review and Network Meta-analysis
por: Tong, Xinyu, et al.
Publicado: (2023)

Effect of Levocarnitine on the Therapeutic Efficacy of Conventional Therapy in Children with Dilated Cardiomyopathy: Results of a Randomized Trial in 29 Children
por: Wang, Yuwen, et al.
Publicado: (2018)

Dilated cardiomyopathies and non-compaction cardiomyopathy
por: Hänselmann, A., et al.
Publicado: (2020)

The Molecular Role of Immune Cells in Dilated Cardiomyopathy
por: Wang, Enping, et al.
Publicado: (2023)

Dilated cardiomyopathy and aldosteronoma: a causal link?
por: Zhang, Jiyu, et al.
Publicado: (2019)

Cushing Syndrome in the Setting of Chronic Dilated Cardiomyopathy: Can Treatment Improve Chronic Dilated Cardiomyopathy?
por: Pathak, Leilani, et al.
Publicado: (2021)

Carvedilol in hypertension treatment
por: Stafylas, Panagiotis C, et al.
Publicado: (2008)

Cardiomyopathy, familial dilated
por: Taylor, Matthew RG, et al.
Publicado: (2006)

Dilated cardiomyopathy in childhood
por: Franklin, OM, et al.
Publicado: (2000)

Immunoadsorption in dilated cardiomyopathy
por: Wakabayashi, Y, et al.
Publicado: (2009)

Carvedilol—NSBB of Choice in All Cirrhotics? Short Title: Carvedilol for Portal Hypertension
por: Tandon, Puneeta, et al.
Publicado: (2015)

Speckle tracking echocardiography in hypokinetic non‐dilated cardiomyopathy: comparison with dilated cardiomyopathy
por: Mombeini, Hoda, et al.
Publicado: (2020)

Assessment of myocardial function in obstructive hypertrophic cardiomyopathy cats with and without response to medical treatment by carvedilol
por: Suzuki, Ryohei, et al.
Publicado: (2019)

The Lack of Synergy between Carvedilol and the Preventive Effect of Dexrazoxane in the Model of Chronic Anthracycline-Induced Cardiomyopathy
por: Szponar, Jaroslaw, et al.
Publicado: (2023)

Carvedilol for Prevention of Atrial Fibrillation after Cardiac Surgery: A Meta-Analysis
por: Wang, Hui-Shan, et al.
Publicado: (2014)

Clinical effects of carvedilol and trimetazidine for the treatmentof alcoholic myocardiopathy
por: Li, Hui, et al.
Publicado: (2016)

Assessment of clinical effect and treatment quality of immediate-release carvedilol-IR versus SLOW release carvedilol-SR in Heart Failure patients (SLOW-HF): study protocol for a randomized controlled trial
por: Choi, Dong-Ju, et al.
Publicado: (2018)

The effect of carvedilol and propranolol on portal hypertension in patients with cirrhosis: a meta-analysis
por: Chen, Sheng, et al.
Publicado: (2015)

Peripartum cardiomyopathy and dilated cardiomyopathy: different at heart
por: Bollen, Ilse A. E., et al.
Publicado: (2015)

Histopathologic features of alcoholic cardiomyopathy compared with idiopathic dilated cardiomyopathy
por: Li, Xuebiao, et al.
Publicado: (2018)

Bioinformatics analysis to screen for genes related to myocardial infarction
por: Yang, Liting, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_8tjve3jb8ma9fgop3uopptfarp